Momentum Stocks in Healthcare: Avidity Biosciences and Henry Schein at Risk

Two health care stocks, Avidity Biosciences Inc (RNA) and Henry Schein Inc (HSIC), are flashing warning signs to investors due to high RSI values. Avidity Biosciences reported quarterly losses that missed analyst estimates, while Henry Schein has a 71.1 RSI value and a recent price target of $86. Both stocks have gained significantly over the past six months, with RNA up 141% and HSIC up 6%.